Then, we transfected the CDC20 overexpression plasmid into PRMT6-silenced GBM cells to achieve CDC20 re-expression, and found that the expression of CDKN1B was downregulated (Fig. 5B). The gene discussed is CDKN1B; the disease is glioblastoma.